Trial intelligence / Profile preview

Efficacy and Safety of FLORANBIDIN in Patients with Chronic Insomnia

TCTR20250910002Phase 2Completed

Sponsor
National Innovation Agency
Start
Mar 2025
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Insomnia, sponsored by National Innovation Agency. Started Mar 2025; status: completed.

02

Conditions

Insomnia

Beyond the preview

Go deeper on TCTR20250910002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250910002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call